IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Knoll Capital Management, LLC

Q1 2019 Holdings

Filed 2019-05-15 | 17 holdings | $6.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aldeyra Therapeutics Inc(ALDX)COM01438T106$4.4M484,09665.2%
Anavex Life Sciences Corp(AVXL)COM NEW032797300$2.2M724,20532.9%
Biohaven Pharmactl Hldg Co L(BHVN)COMG11196105$38.6K749,8150.6%
Corbus Pharmaceuticals Hldgs(CRBPEUR)COM21833P103$34.7K4,985,8700.5%
Abeona Therapeutics Inc(ABEO1EUR)COM00289Y107$17.4K2,359,7670.3%
Krystal Biotech Inc(KRYS)COM501147102$6.9K209,9860.1%
Blackstone Group LP(BXUSD)COM UNIT LTD09253U108$5.4K153,0000.1%
Altria Group Inc(MO)COM02209S103$5.2K90,0000.1%
DowDupont IncCOM26078J100$4.8K90,0000.1%
Kraneshares TR(KBA)BOSERA MSCI CH500767405$3.1K96,0000.0%
Electrocore Inc(ECORGBP)COM28531P103$2.8K396,8250.0%
Entera Bio Ltd(ENTX)SHSM40527109$2.1K475,5400.0%
Galmed Pharmaceuticals Ltd(GLMD)SHSM47238106$1.7K206,0990.0%
Eiger Biopharmaceuticals Inc(CLDNEUR)COM28249U105$1.1K75,2380.0%
Soligenix Inc.COM834223307$767837,8000.0%
Molecular TemplatesCOM608550109$662113,9050.0%
Lipocine Inc NewCOM53630X104$11650,0000.0%